Envista Holdings shareholders elect directors and approve proposals at annual meeting
Envista Holdings Corporation (NYSE:NVST) held its 2026 Annual Meeting of Stockholders, where shareholders elected all eight director nominees for one-year terms. They also ratified Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 and approved the compensation for named executive officers. The company adopted a policy to hold annual advisory votes on executive compensation, following shareholder preference.
Envista (NYSE: NVST) investors approve board, auditor and annual say-on-pay
Envista Holdings Corporation (NYSE: NVST) stockholders approved all key proposals at their 2026 Annual Meeting. They re-elected eight directors for one-year terms, ratified Ernst & Young LLP as the independent auditor for 2026, and approved the company's named executive officer compensation on an advisory basis. Stockholders also overwhelmingly supported holding future advisory say-on-pay votes annually.
Envista (NVST) director Huennekens receives 12,585 RSUs in equity grant
Envista Holdings Corp (NVST) director R. Scott Huennekens has been granted 12,585 Restricted Stock Units (RSUs) as part of his annual equity compensation for board service. These RSUs, granted at no cash cost, will vest on the first anniversary of the grant date and convert into one share of common stock per RSU. Following this grant, Huennekens directly holds 82,105 shares of Envista common stock, aligning his interests with shareholders.
Aristotle Small Cap Equity Fund Picked Envista Holdings (NVST) Citing Varied Growth Signals
Aristotle Small Cap Equity Fund has added Envista Holdings Corporation (NVST) to its portfolio, as detailed in its Q1 2026 investor letter. The fund believes Envista, a dental products company, offers exposure to a growing dental market with potential for margin recovery and an attractive valuation. Despite Envista's presence in 36 hedge fund portfolios, the fund suggests some AI stocks might offer higher and quicker returns.
NVST Stock Price Prediction 2025-2026 | Envista Holdings Corp Forecast
24/7 Wall St. rates Envista Holdings Corp (NVST) as a BUY with a 12-month target price of $33.90, suggesting a 46.44% upside from its current price of $23.15. The analysis includes optimistic and conservative scenarios, projecting NVST could reach $37.30 and $28.16 respectively. Long-term forecasts for 2030 indicate an average price of $53.78, with analysts largely favorable towards the stock, highlighting strong earnings growth and sector tailwinds as key catalysts.
Envista Holdings Corp (NYSE:NVST) Q1 2026 Earnings Call Transcript
Envista Holdings Corp (NYSE: NVST) reported a strong start to 2026 with Q1 core growth of 9.5%, exceeding earnings expectations with an EPS of $0.36 against an expected $0.31. The company saw broad-based performance across its portfolio, including double-digit growth in Ortho consumables and diagnostics, while reaffirming its full-year 2026 guidance and authorizing an additional $300 million for share repurchases. Despite macro uncertainties and potential VBP impacts in China, Envista highlighted improved execution, operational discipline, and strategic investments in new products and an accretive tuck-in acquisition (Versah) as drivers for its continued momentum.
Envista Holdings Corporation Common Stock (NY: NVST
This compilation provides recent news and financial updates for Envista Holdings Corporation (NYSE:NVST). It features headlines covering Q1 2026 earnings results, analyst insights, product launches, and broader healthcare industry analysis. The articles highlight Envista's financial performance, market reactions, and related stock movements.
Envista Q1 2026 slides: 9.5% core growth drives 50% EPS surge
Envista Holdings Corporation reported strong Q1 2026 results with 9.5% core sales growth and a 50% year-over-year increase in adjusted earnings per share, despite a 7.25% stock decline in after-hours trading. The company affirmed its full-year 2026 guidance, highlighting broad-based momentum across its dental product segments, strategic acquisitions, and new product launches as key growth drivers. Envista also authorized an additional $300 million for share repurchases, signaling confidence in its financial outlook.
Earnings call transcript: Envista Holdings beats Q1 2026 forecasts but stock dips
Envista Holdings (NVST) reported strong Q1 2026 financial results, exceeding EPS and revenue forecasts, but its stock declined by 7.25% in after-hours trading due to broader market conditions and future guidance. The company achieved 9.5% year-over-year core revenue growth and a 25% increase in adjusted EBITDA, driven by new product launches and strategic acquisitions. Envista reaffirmed its full-year 2026 guidance and authorized an additional $300 million share repurchase program, demonstrating confidence despite ongoing macro volatility and potential supply chain risks.
Morgan Stanley and Atlanta Capital report holdings in Envista (NYSE: NVST)
Morgan Stanley and Atlanta Capital Management have filed amended Schedule 13G/A forms reporting their institutional holdings in Envista Holdings Corp (NYSE: NVST). Both firms indicate they have ceased to be beneficial owners of more than five percent of the class of securities as of the filing date, May 11, 2026. Morgan Stanley reports beneficial ownership of 4.4%, while Atlanta Capital Management reports 3.7%.
NVST SEC Filings - Envista Holdings Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors and traders to access Envista Holdings Corporation (NVST) SEC filings. It details the types of documents available, such as 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms, along with their content and significance. The platform offers AI-powered summaries, impact scoring, and sentiment analysis for these regulatory documents.
Envista Down Nearly 10%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Envista Holdings Corporation's stock is experiencing a significant drop of nearly 10%, putting it on track for its largest percentage decrease since March 2020. This downturn follows previous market actions, including a recent rally and a three-day losing streak that saw 7.1% wiped off its market value. The stock is trading below its 50-day moving average, signaling increased bearish sentiment.
Earnings call transcript: Envista Holdings beats Q1 2026 forecasts, stock rises
Envista Holdings Corp. (NVST) reported strong Q1 2026 financial results, surpassing analyst expectations with an EPS of $0.36 and revenue of $706 million. Following the announcement, the stock rose by 1.57% in after-hours trading, reflecting positive investor sentiment driven by robust growth across all business segments and new product launches. The company reaffirmed its full-year 2026 guidance and authorized an additional $300 million for share repurchases, balancing organic growth investments with shareholder returns.
Envista Q1 2026 slides: 9.5% core growth drives 50% earnings jump
Envista Holdings Corp. reported robust Q1 2026 results with adjusted earnings per share of $0.36, a 50% year-over-year increase, and revenue of $706 million, exceeding analyst expectations. The company achieved 9.5% core sales growth, driven by strong performance across both Specialty Products & Technologies and Equipment & Consumables segments. Envista also reaffirmed its full-year 2026 guidance and authorized an additional $300 million for share repurchases, highlighting confidence in its strategic initiatives and operational excellence.
Envista: Q1 Earnings Snapshot
Envista Holdings Corp. reported strong first-quarter earnings, with net income totaling $38.7 million. The company exceeded Wall Street's expectations with adjusted earnings of 36 cents per share on revenue of $705.5 million. Envista also provided a full-year earnings forecast in the range of $1.35 to $1.45 per share.
Envista (NYSE:NVST) Posts Better-Than-Expected Sales In Q1 CY2026
Envista Holdings (NYSE:NVST) exceeded Wall Street's revenue and adjusted EPS expectations in Q1 CY2026, with sales increasing 14.4% year-on-year to $705.5 million and adjusted EPS reaching $0.36. Despite a solid quarter, including reaffirmed full-year Adjusted EPS guidance, investors reacted by trading shares down 1.1% immediately after the report. The company's long-term revenue growth has been mediocre, and its adjusted operating margin has decreased over the last five years, indicating challenges in profitability management.
Envista (NYSE: NVST) posts Q1 2026 growth, boosts margins and buybacks
Envista Holdings Corporation (NYSE: NVST) reported strong first-quarter 2026 results, with sales up 14.4% year-on-year to $705.5 million and adjusted diluted EPS increasing 50% to $0.36. The company also improved its adjusted EBITDA margin to 14.0% and authorized an additional $300 million stock repurchase program. Envista reaffirmed its full-year 2026 guidance, demonstrating confidence in continued growth and profitability despite a negative operating cash flow in Q1.
Envista Reports First Quarter 2026 Results
Envista Holdings Corporation (NYSE: NVST) announced strong first-quarter 2026 results, reporting $706 million in sales with 9.5% core sales growth, and significant increases in adjusted EBITDA (+25%) and adjusted diluted EPS (+50%). The company highlighted broad-based growth across all major businesses, driven by customer engagement and new product commercialization. Envista reaffirmed its full-year 2026 guidance and authorized an incremental $300 million share repurchase program.
Envista earnings in focus as dental leader tests momentum
Envista Holdings Corp. is poised to release its first-quarter results, with analysts anticipating earnings per share of $0.31 and revenue of $680.52 million. Investors will be observing whether the company can sustain market share gains, particularly in specialty products and equipment, and continue its margin expansion efforts. Envista's performance will also be assessed against its full-year guidance and its ability to leverage digital dentistry trends, especially after a strong fourth-quarter showing in 2025.
Envista (NVST) Q1 Earnings: What To Expect
Envista Holdings (NVST) is set to report its Q1 earnings this Wednesday. The market anticipates a 9.5% year-on-year revenue growth, a turnaround from last year's decrease, following a strong previous quarter where Envista beat revenue and EPS estimates. Investors are looking for continued positive performance, especially given mixed results from peers like Align Technology and Intuitive Surgical.
Envista Holdings Corp. (NVST) Jumps on Earnings Beat as Market Share Gains Accelerate
Ariel Investments' Q1 2026 investor letter highlighted Envista Holdings Corporation (NVST) as a top pick after the company beat earnings expectations. The dental products company saw broad-based strength, continued market share gains in specialty products and equipment, and strong momentum in key dental solutions. Ariel Investments maintains confidence in NVST due to its innovation, exposure to long-term dental growth categories, and operational efficiencies.
Morgan Stanley Raises Envista Holdings Price Target Amid Dental Trends
Morgan Stanley increased its price target for Envista Holdings Corporation (NVST) to $21 from $19, maintaining an Equal Weight rating, despite a slowdown in the U.S. dental market. The firm observed diverging trends, with general practice activity sluggish but an uptick in specific orthodontic and restorative categories. Separately, Citi initiated coverage of Envista Holdings with a Neutral rating and a $29 price target, viewing the dental sector with cautious optimism due to economic pressures shifting consumer preferences towards lower-cost treatments, contrasting with a more favorable outlook for animal health.
Here’s What Analysts Are Saying About Envista (NVST)
Morgan Stanley reiterated an Equal Weight rating for Envista Holdings Corporation (NYSE:NVST) and raised its price target from $19 to $21, citing weaker practice volumes but improved specialty segment demand. Citi initiated coverage with a Neutral rating and a $29 price target, noting pressures in the dental sector due to a weak economic environment. The article highlights Envista's role as a global dental products company with a focus on implants, orthodontics, and digital imaging.
10 Best Medical Stocks to Buy Under $30
This article highlights Envista Holdings Corporation (NYSE:NVST) as one of the top medical stocks to buy under $30. Morgan Stanley recently increased its price target for NVST to $21 due to improved demand in its Specialty segment, despite weaker practice volumes in Q1. Citi also initiated coverage with a Neutral rating and a $29 price target, noting the company's strong portfolio in dental implants, orthodontics, and digital imaging.
10 Best Medical Stocks to Buy Under $30
This article highlights Envista Holdings Corporation (NYSE:NVST) as one of the top medical stocks to buy under $30. It details recent analyst ratings from Morgan Stanley and Citi, noting Morgan Stanley raised its price target to $21 while Citi initiated coverage with a Neutral rating and a $29 price target. The company, a global dental products firm with over 30 brands, faces a challenging economic environment for the dental sector but sees some improvement in its specialty segment.
Envista (NVST) Projected to Post Quarterly Earnings on Wednesday
Envista (NVST) is projected to announce its Q1 2026 earnings on Wednesday, May 6, 2026, with analysts expecting $0.31 EPS and $677.95 million in revenue. The company previously exceeded estimates in the last quarter, reporting $0.38 EPS against an expected $0.32, and its revenue increased by 15% year-over-year. Currently, NVST shares trade near $26.28, with a consensus "Hold" rating from analysts and a target price of $28.25.
Vanguard shows 8.57M-share stake in Envista (NVST) in Schedule 13G
Vanguard Capital Management has disclosed an 8,574,557-share stake in Envista Holdings Corp (NVST), representing 5.23% of the company's common stock as of March 31, 2026. This Schedule 13G filing indicates Vanguard holds sole dispositive power over all these shares and sole voting power over 1,255,976 shares. The investment is described as being in the ordinary course of business and not for the purpose of influencing control of the issuer.
Envista (NYSE:NVST): Strongest Q4 Results from the Dental Equipment & Technology Group
Envista Holdings (NYSE: NVST) reported the strongest Q4 results among its peers in the dental equipment and technology sector, with revenues reaching $750.6 million, a 15% year-on-year increase and 10.6% above analyst expectations. Other companies like Henry Schein (NASDAQ: HSIC) and Align Technology (NASDAQ: ALGN) also beat revenue estimates, while Dentsply Sirona (NASDAQ: XRAY) had a softer quarter despite exceeding revenue expectations. The article highlights the industry's strong Q4 performance, with overall revenues beating consensus by 4.7%, and discusses market trends for the sector.
Envista (NYSE:NVST) Price Target Raised to $21.00 at Morgan Stanley
Morgan Stanley has raised its price target for Envista (NYSE:NVST) to $21.00 from $19.00 but maintained an "equal weight" rating, implying a potential 22.4% downside from the current stock price. Despite varying analyst ratings, the consensus remains a "Hold" with an average price target of $27.85. The article notes significant institutional buying while an SVP recently sold shares, with insiders owning about 0.99% of the stock.
New dental sealer targets 57 canals per syringe with 33.5% less waste
Kerr Dental has launched ZenSeal Pro with ZenSave Tips, a new bioceramic sealer system designed to enhance delivery efficiency and reduce material waste. The system allows for an average of 57 canals to be treated per 1.5g syringe, a significant increase compared to competitors, and reduces waste by 33.5%. This innovation is estimated to save dental practices over $1,500 annually while maintaining high performance and supporting various obturation techniques.
This dental curing light adds 360° access and built-in output checks
Kerr Dental has launched Demi™ Pro, a new cordless curing light designed for improved ergonomics, 360° access, and deeper cures. The device features a lightweight, balanced aluminum body with a pen-style grip, a fully rotatable low-profile tip, and safety features including an integrated radiometer and overheating protection. Demi™ Pro also offers an optional transillumination tip for diagnostic purposes.
Citigroup initiates coverage of Envista Holdings (NVST) with neutral recommendation
Citigroup has initiated coverage on Envista Holdings (NVST) with a "Neutral" recommendation. This new coverage provides investors with an analyst perspective on the company.
NVST Initiated by Citigroup -- Price Target Announced at $29.00
Citigroup has initiated coverage on Envista Holdings (NVST) with a Neutral rating and a price target of $29.00. The stock is currently trading at a 17.3% premium to its GF Value, suggesting it is overvalued, with a P/E ratio significantly higher than its 5-year median. Despite strong financial strength and profitability, its growth rank is moderate, and recent insider activity shows no buying.
Citigroup Initiates Envista Holdings at Neutral With $29 Price Target
Citigroup has initiated coverage on Envista Holdings (NVST) with a "Neutral" rating and a price target of $29. This follows recent analyst activity for Envista, including Leerink upgrading the stock to Outperform and Mizuho upgrading it to Neutral, while UBS adjusted its price target. Envista Holdings is a dental products company that manufactures and markets dental consumables, solutions, technology, and services across two segments: Specialty Products & Technologies and Equipment & Consumables.
Envista Holdings Corp. Opens with a 5.5% Gain Amid Mixed Financial Indicators
Envista Holdings Corp. experienced a significant 5.5% gain at market open, contrasting with broader market trends. Despite this positive movement, the company faces challenges including low profitability, negative net profit growth, and mixed technical indicators. Envista, a small-cap player in the Pharmaceuticals & Biotechnology sector, is working to improve its market position amidst these financial complexities.
81,686 Shares in Envista Holdings Corporation $NVST Bought by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL purchased 81,686 shares of Envista Holdings Corporation (NYSE:NVST) in the third quarter, valued at approximately $1.66 million. Several other institutional investors also increased their holdings in Envista. Analysts currently hold a "Hold" consensus rating for NVST with an average price target of $27.58, following recent adjustments from various firms.
Envista Schedules First Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) is scheduled to report its first-quarter 2026 financial results on Wednesday, May 6, 2026. The company will host a conference call on the same day at 2:00 PM PT to discuss these results. The announcement was made via PR Newswire.
Envista Schedules First Quarter 2026 Earnings Call – Company Announcement
Envista Holdings Corporation (NYSE: NVST) will release its first quarter 2026 financial results on Wednesday, May 6, 2026, followed by a conference call and webcast at 2:00 PM PT. The call will be accessible via dial-in and webcast on the "Investors" section of Envista's website, where presentation materials will also be posted. Envista, a global leader in the dental industry with over 30 brands, will discuss its performance and future outlook.
Envista Schedules First Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) announced it will report its first-quarter 2026 financial results on Wednesday, May 6, 2026. The company will host a conference call and webcast on the same day at 2:00 PM PT to discuss these results. Interested parties can access the webcast and related materials on Envista's investor relations website.
Envista Schedules First Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) has announced its first-quarter 2026 earnings call for Wednesday, May 6, 2026, at 2:00 PM PT. The company will discuss its financial results, and the call will be webcast on Envista's website with a replay available for one year. Envista, a global leader in the dental industry with over 30 brands, will also post related press releases and presentation materials on its investor relations section.
Envista to post Q1 results May 6, with webcast at 2 p.m. PT
Envista Holdings Corporation (NYSE: NVST) will release its first-quarter 2026 financial results on Wednesday, May 6, 2026. The company will host a conference call and webcast on the same day at 2:00 PM PT to discuss these results. Investors can access the webcast on Envista's website, and presentation materials will be made available before the call.
[ARS] Envista Holdings Corp SEC Filing
This article announces an ARS SEC filing by Envista Holdings Corp (NVST) on April 7, 2026, which has a low impact and neutral sentiment. It provides details on the filing, including its type and acceptance date, and offers access to the full PDF document. The report also lists recent news and other SEC filings related to Envista Holdings Corp, alongside key stock data.
Envista Schedules First Quarter 2026 Earnings Call
Envista Holdings Corporation (NYSE: NVST) will report its first quarter 2026 financial results on Wednesday, May 6, 2026. The company will host a conference call on the same day at 2:00 PM PT to discuss these results, with a webcast available on its website. Envista, a global leader in the dental industry, unites over 30 brands to improve patients' lives by partnering with dental professionals.
Envista (NYSE: NVST) outlines 2026 virtual meeting, proposals and 2025 results
Envista Holdings Corporation (NYSE: NVST) has detailed its 2026 virtual annual meeting, scheduled for May 19, 2026, where stockholders will vote on electing eight directors, ratifying Ernst & Young LLP as the auditor, and casting an advisory vote on executive compensation and its frequency. The company reported strong financial results for 2025, with total revenue of $2,719.5 million and net income of $47.0 million, alongside significant improvements in Adjusted EBITDA and diluted EPS. Envista also highlighted its corporate governance framework, commitment to sustainability, and executive compensation practices designed to align with stockholder interests and performance.
Best Value Stocks to Buy for March 16th
This article identifies three top-ranked value stocks for March 16th: OptimizeRx Corporation (OPRX), Envista Holdings Corporation (NVST), and Strattec Security Corporation (STRT). Each company holds a Zacks Rank #1, indicating strong earnings estimate revisions, and exhibits favorable price-to-earnings ratios compared to their respective industries or the S&P 500, along with strong Value Scores. The report suggests these stocks offer potential for investors seeking value opportunities.
Tudor Investment Corp ET AL Purchases New Holdings in Envista Holdings Corporation $NVST
Tudor Investment Corp ET AL has acquired a new position of 81,686 shares in Envista Holdings Corporation (NYSE:NVST), valued at approximately $1.664 million, as per its recent SEC disclosure. Envista recently beat quarterly earnings expectations with $0.38 EPS against a $0.32 consensus and reported a 15% year-over-year revenue increase. The company has also set its FY2026 EPS guidance between $1.350 and $1.450.
Vanguard disaggregates holdings; reports 0 Envista shares (NVST)
The Vanguard Group filed an amended Schedule 13G, reporting 0 shares of Envista Holdings Corp common stock following an internal realignment. This change means certain Vanguard subsidiaries will now report beneficial ownership separately, as per SEC Release No. 34-39538. The filing clarifies that this is a reporting re-allocation, not an actual sale or change in economic ownership of Envista shares by underlying funds.
Envista Holdings Corp (0HV.DE) Fundamental Analysis
Envista Holdings Corp (0HV.DE) exhibits weak financial fundamentals, receiving a Fundamental Health Score of 26.2/100 due to low profitability, weak growth trends, and a high PE ratio. Despite some balanced valuation metrics and a strong balance sheet, the company struggles with efficiency, reflected in its ROE, operating margin, and negative revenue growth. Its performance lags behind sector averages in most key metrics, though it shows strong liquidity.
Envista Holdings Corp (NVST) Shares Down 3.09% on Mar 18
Envista Holdings Corp (NVST) shares dropped 3.09% on March 18, closing at $25.25. While this is 17.01% below its 52-week high, it remains 77.53% above its 52-week low. Wall Street analysts forecast an average target price of $28.91 for NVST, indicating a potential 14.51% upside, with a consensus "Outperform" rating from brokerage firms.
A Look At Envista Holdings (NVST) Valuation After Recent Share Price Volatility
Envista Holdings (NVST) has seen recent share price volatility, with a 14% decline over the past month but a 14% total return over the last three months. The company is considered 12.1% undervalued with a fair value of $28.46, driven by increasing R&D and successful product launches in digital dentistry. However, its current P/E ratio of 87.2x is significantly higher than the industry average, suggesting potential valuation risk.
